Published in Neuroradiology on May 15, 2013
Histologic validation of locus coeruleus MRI contrast in post-mortem tissue. Neuroimage (2015) 0.88
A multicontrast approach for comprehensive imaging of substantia nigra. Neuroimage (2015) 0.84
Diffusion tensor imaging of the substantia nigra in Parkinson's disease revisited. Hum Brain Mapp (2016) 0.83
Neuromelanin-sensitive magnetic resonance imaging: a promising technique for depicting tissue characteristics containing neuromelanin. Neural Regen Res (2014) 0.79
Blood pressure fluctuation and hypertension in patients with Parkinson's disease. Brain Behav (2013) 0.78
The Neuromelanin-related T2* Contrast in Postmortem Human Substantia Nigra with 7T MRI. Sci Rep (2016) 0.77
Principal Component Analysis of Multimodal Neuromelanin MRI and Dopamine Transporter PET Data Provides a Specific Metric for the Nigral Dopaminergic Neuronal Density. PLoS One (2016) 0.77
Correlation between neuromelanin-sensitive MR imaging and (123)I-FP-CIT SPECT in patients with parkinsonism. Neuroradiology (2016) 0.77
Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease. Front Aging Neurosci (2016) 0.76
Quantitative Susceptibility Mapping Indicates a Disturbed Brain Iron Homeostasis in Neuromyelitis Optica - A Pilot Study. PLoS One (2016) 0.76
A Comparison of Substantia Nigra T1 Hyperintensity in Parkinson's Disease Dementia, Alzheimer's Disease and Age-Matched Controls: Volumetric Analysis of Neuromelanin Imaging. Korean J Radiol (2016) 0.76
In vivo detection of lateral-ventral tier nigral degeneration in Parkinson's disease. Hum Brain Mapp (2017) 0.76
Utility of susceptibility-weighted imaging in Parkinson's disease and atypical Parkinsonian disorders. Transl Neurodegener (2016) 0.75
Pool size ratio of the substantia nigra in Parkinson's disease derived from two different quantitative magnetization transfer approaches. Neuroradiology (2017) 0.75
A novel computerized algorithm to detect microstructural brainstem pathology in Parkinson's disease using standard 3 Tesla MR imaging. J Neurol (2014) 0.75
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology (1996) 12.33
The effect of age on the non-haemin iron in the human brain. J Neurochem (1958) 4.83
Paramagnetic metal scavenging by melanin: MR imaging. Radiology (1997) 1.60
T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content. Radiology (1999) 1.52
Measurements of T1 and T2 over time in formalin-fixed human whole-brain specimens. Acta Radiol (1992) 1.49
Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease. Neuroreport (2006) 1.37
T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease. Mov Disord (2011) 1.14
Visualization of neuromelanin in the Substantia nigra and locus ceruleus at 1.5T using a 3D-gradient echo sequence with magnetization transfer contrast. Magn Reson Med Sci (2008) 0.97
On the origin and significance of neuromelanin. Arch Pathol Lab Med (1979) 0.96
Studies on neuromelanin. I. A melanin system in the human adult brainstem. Neurology (1967) 0.93
Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson's disease. J Clin Neurosci (2011) 0.92
Reduction of neuromelanin-positive nigral volume in patients with MSA, PSP and CBD. Intern Med (2011) 0.86
BRAIN PIGMENT AND ITS RELATION TO BRAIN CATECHOLAMINES. Lancet (1965) 0.82
Postmortem MRI of the brain with neuropathological correlation. Neuroradiology (1995) 0.82
Postmortem MR imaging of lobar cerebral infarction with pathologic and in vivo correlation. Radiographics (1996) 0.80
Curvilinear T1 hyperintense lesions representing cortical necrosis after cerebral infarction. Neuroradiology (2005) 0.80
Sources of the increased longitudinal relaxation rates observed in melanotic melanoma. An in vitro study of synthetic melanins. Invest Radiol (1989) 0.77